Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

OCCUPATIONAL AIRBORNE CONTACT DERMATITIS TO OMEPRAZOLE (CROSBI ID 636510)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Jurakic Toncic, Ružica ; Ljubojević Hadžavdić, Suzana ; Turcic, Petra OCCUPATIONAL AIRBORNE CONTACT DERMATITIS TO OMEPRAZOLE // European Academy of Allergy and Clinical Immunology - Abstract Book. 2015. str. 221-x

Podaci o odgovornosti

Jurakic Toncic, Ružica ; Ljubojević Hadžavdić, Suzana ; Turcic, Petra

engleski

OCCUPATIONAL AIRBORNE CONTACT DERMATITIS TO OMEPRAZOLE

Omeprazole is a proton pump inhibitor for the treatment of gastric acid-related disorders. It is administered orally. We present 52-years-old chemist who worked in a pharmaceutical company for 5 years and she was exposed to omeprazole during the manufacturing process. When working in the laboratory, she was wearing protective latex free gloves. Whenever they were manufacturing omeprazole she had eczema with scaling on the eyelids face and neck, later hands were also affected. When she was on sick leave or when she was on vacation she had completely regression of skin dermatitis. The patient was treated with topical corticosteroids, which resulted with temporally regression of skin symptoms. We preformed lymphocyte transformation test (LTT) which was negative. Patch test to baseline series was negative, but patch test to omeprazole (0.1% and 0.5% in saline solution) was positive at day 2 (+) and day 3 (++). Conclusions: Omeprazole constitute a high- sensitizing chemical. Although direct contact with the skin is not always present, distribution of dust containing omeprazole through the air and deposition on exposed areas may result in an airborne pattern of contact dermatitis. Our case confirms the risk of sensitization to omeprazole from occupational exposure.

Omeprasole; proton pump inhibitor; eczema

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

221-x.

2015.

objavljeno

Podaci o matičnoj publikaciji

European Academy of Allergy and Clinical Immunology - Abstract Book

Podaci o skupu

European Academy of Allergy and Clinical Immunology

poster

06.06.2015-10.06.2015

Barcelona, Španjolska

Povezanost rada

Kliničke medicinske znanosti